Haji et al., 1994 - Google Patents
Sertoli cell function declines earlier than Leydig cell function in aging Japanese menHaji et al., 1994
- Document ID
- 8921498354402884146
- Author
- Haji M
- Tanaka S
- Nishi Y
- Yanase T
- Takayanagi R
- Hasegawa Y
- Sasamoto S
- Nawata H
- Publication year
- Publication venue
- Maturitas
External Links
Snippet
In order to evaluate the age-related changes in Leydig cell and Sertoli cell function, we measured serum levels of total testosterone (TT), free testosterone (FT), inhibin, LH and FSH in 116 healthy Japanese men, aged 24–92 years. Serum TT remained constant up to the …
- 210000000717 Sertoli cell 0 title abstract description 20
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Haji et al. | Sertoli cell function declines earlier than Leydig cell function in aging Japanese men | |
Alviggi et al. | Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism | |
Giudice et al. | Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia | |
Bazer et al. | Physiological mechanisms ofpregnancy recognition in ruminants | |
SOULES et al. | Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle | |
le Cotonnec et al. | Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone | |
Flack et al. | Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line | |
Ajala et al. | Changes in serum leptin during phases of menstrual cycle of fertile women: relationship to age groups and fertility | |
Wada et al. | Macrophage migration inhibitory factor in the human ovary: presence in the follicular fluids and production by granulosa cells | |
Rabinovici et al. | Insulin-like growth factor I (IGF-I) levels in follicular fluid from human preovulatory follicles: correlation with serum IGF-I levels | |
Advis et al. | Delayed puberty induced by chronic suppression of prolactin release in the female rat | |
Dorn et al. | Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization | |
Moy et al. | Glycoprotein hormone alpha-subunit functions synergistically with progesterone to stimulate differentiation of cultured human endometrial stromal cells to decidualized cells: a novel role for free alpha-subunit in reproduction | |
Seppälä et al. | Glycodelins | |
Tsonis et al. | Gonadotropic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle | |
Drummond et al. | Temporal and hormonal regulation of inhibin protein and subunit mRNA expression by post-natal and immature rat ovaries | |
Illingworth et al. | The source of inhibin secretion during the human menstrual cycle | |
Warren et al. | Cellular localization of corticotrophin releasing hormone in the human placenta, fetal membranes and decidua | |
Fedorcsak et al. | Impaired insulin action on granulosa-lutein cells in women with polycystic ovary syndrome and insulin resistance | |
Kisielewska et al. | Expression of chemerin receptors CMKLR1, GPR1 and CCRL2 in the porcine pituitary during the oestrous cycle and early pregnancy and the effect of chemerin on MAPK/Erk1/2, Akt and AMPK signalling pathways | |
Jiang et al. | Improvement of follicular development rather than gonadotrophin secretion by thyroxine treatment in infertile immature hypothyroid rdw rats | |
Dees et al. | Effects of castration and ethanol on amygdaloid substance P immunoreactivity | |
MacLennan | Relaxin–a review | |
Fry et al. | Relationships between follicle-stimulating hormone, follicle growth and ovulation rate in sheep | |
Yamaguchi et al. | Interleukin 6 inhibits mouse placental lactogen II but not mouse placental lactogen I secretion in vitro. |